603669 灵康药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.475-27.803-15.377-14.668-15.104
总资产报酬率 ROA (%)0.265-16.362-9.081-8.707-8.964
投入资产回报率 ROIC (%)0.305-19.197-10.029-9.094-9.260

边际利润分析
销售毛利率 (%)28.84643.71346.88146.67267.809
营业利润率 (%)4.104-60.770-33.906-75.690-65.226
息税前利润/营业总收入 (%)9.946-40.554-33.207-76.447-65.670
净利润/营业总收入 (%)3.416-59.922-34.431-76.967-67.711

收益指标分析
经营活动净收益/利润总额(%)81.36186.85667.780103.96389.066
价值变动净收益/利润总额(%)43.2351.5395.3399.6284.300
营业外收支净额/利润总额(%)-12.598-1.271-0.8141.3080.069

偿债能力分析
流动比率 (X)1.1471.0982.6753.6263.743
速动比率 (X)0.9830.9222.5483.3933.581
资产负债率 (%)44.43743.95638.68142.69038.849
带息债务/全部投入资本 (%)35.79934.20026.49839.19036.010
股东权益/带息债务 (%)177.103189.971274.441153.346176.783
股东权益/负债合计 (%)125.039127.500158.526134.249157.405
利息保障倍数 (X)1.578-2.085-78.049-310.910164.745

营运能力分析
应收账款周转天数 (天)280.350278.698145.938143.506134.245
存货周转天数 (天)117.884110.97675.527181.612194.865